Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT
Matinas BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.92M | 7.28M | 10.29M | 4.22M | 1.12M | 4.84M | 6.41M | 9.74M | 5.74M | 6.83M | 11.18M | 10.4M | 19.33M | 21.03M | 24.92M | 30.35M | 23.38M |
Short-Term Investments | n/a | n/a | 500K | 10.1M | 7.04M | 8.97M | 11.81M | 12.77M | 19.12M | 21.93M | 21.88M | 28.1M | 24.54M | 28.59M | 28.91M | 29.49M | 37.28M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 200K | n/a | n/a | n/a | 200K | n/a | n/a | n/a | 28.59M | n/a | n/a | n/a |
Other Long-Term Assets | 200K | 200K | 200K | 200K | 200K | n/a | 200K | 200K | 200K | -34.05M | 200.1K | 199.97K | 200.32K | 200K | 199.72K | 199.75K | 200.3K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.3M |
Other Current Assets | 623K | 741K | 946K | 972K | 50K | 1.79M | 1.77M | 1.49M | 3.35M | 5.77M | 50K | 50K | 50K | 50K | 50K | 136K | 1.44M |
Total Current Assets | 7.55M | 8.03M | 11.74M | 15.29M | 10.29M | 15.54M | 19.99M | 24M | 28.21M | 34.53M | 37.1M | 41.92M | 45.12M | 50.99M | 56.48M | 60.94M | 63.14M |
Property-Plant & Equipment | 2.03M | 2.16M | 4.28M | 4.53M | 4.77M | 5.01M | 5.25M | 5.47M | 5.5M | 5.73M | 5.89M | 5.94M | 6.11M | 5.78M | 5.95M | 4.48M | 4.66M |
Goodwill & Intangibles | 2.26M | 2.26M | 1.34M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M |
Total Long-Term Assets | 4.49M | 4.62M | 8.84M | 9.08M | 9.32M | 50.03M | 9.8M | 10.03M | 10.06M | 10.29M | 10.45M | 10.49M | 10.67M | 10.33M | 10.5M | 9.03M | 9.21M |
Total Assets | 12.04M | 12.64M | 20.58M | 24.36M | 19.61M | 65.58M | 29.79M | 34.02M | 38.26M | 44.82M | 47.55M | 52.42M | 55.78M | 61.33M | 66.98M | 69.97M | 72.35M |
Account Payables | 282K | 95K | 349K | 238K | 473K | 514K | 835K | 604K | 516K | 618K | 656.72K | 497.15K | 1.35M | 937K | 662K | 450.46K | 421.64K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 721K | 1.41M | 2.1M | 702K | 932K | 1.23M | 840K | 186K |
Short-Term Debt | n/a | n/a | n/a | 712K | n/a | 661K | 637K | 613K | 589K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 922K | 4K | 1.00 | -293K | 338K | -390K | -170K | -268K | -308K | 1.39M | 2.23M | 3.32M | 701.75K | 1.51M | 1.95M | 839.74K | 185.75K |
Total Current Liabilities | 2.25M | 2.67M | 2.12M | 2.39M | 2M | 2.62M | 3.23M | 2.59M | 1.9M | 4.29M | 4.9M | 5.38M | 3.77M | 4.35M | 4.1M | 3.59M | 2.22M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.68B | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.68B | n/a | n/a | n/a |
Total Long-Term Liabilities | 3.51M | 2.38M | 2.67M | 2.87M | 3.05M | 43.71M | 3.41M | 3.58M | 3.74M | 3.9M | 4.03M | 4.18M | 4.33M | 4.48M | 4.63M | 3.48M | 3.57M |
Total Liabilities | 5.76M | 5.05M | 4.8M | 5.26M | 5.05M | 46.33M | 6.64M | 6.17M | 5.64M | 8.18M | 8.93M | 9.57M | 8.1M | 8.83M | 8.73M | 7.07M | 5.79M |
Total Debt | 2.71M | 2.89M | 3.07M | 3.24M | 3.4M | 3.56M | 3.71M | 3.85M | 3.99M | 4.12M | 4.23M | 4.43M | 4.57M | 4.7M | 4.83M | 3.51M | 3.63M |
Common Stock | 1K | 1K | 1K | 25K | 22K | 22K | 22K | 22K | 22K | 22K | 21.68K | 21.68K | 21.68K | 21.63K | 21.63K | 21.46K | 20.43K |
Retained Earnings | -201.48M | -199.82M | -191.39M | -187.12M | -181.4M | -175.57M | -170.26M | -164.2M | -158.14M | -152.63M | -149M | -143.54M | -137.61M | -131.63M | -124.93M | -118.1M | -112.46M |
Comprehensive Income | n/a | n/a | n/a | -51K | -134K | -221K | -359K | -514K | -595K | -824K | -935.57K | -754.42K | -629.17K | -145.5K | -1.59K | 51.24K | 136.41K |
Shareholders Equity | 6.27M | 7.59M | 15.78M | 19.1M | 14.56M | 19.25M | 23.15M | 27.85M | 32.63M | 36.64M | 38.62M | 42.85M | 47.68M | 52.49M | 58.25M | 62.9M | 66.56M |
Total Investments | n/a | n/a | 500K | 10.1M | 7.04M | 9.17M | 11.81M | 12.77M | 19.12M | 21.93M | 21.88M | 28.1M | 24.54M | 28.59M | 28.91M | 29.49M | 37.28M |